Spasticity, Muscle Clinical Trial
Official title:
The Effects of EXOPULSE Mollii Suit on Motor Functions in Patients With Multiple Sclerosis (EXOSEP 2)
The goal of this clinical trial is to demonstrate the improvement of motor functions related symptoms in patients with MS and spasticity using Exopulse Mollii suit stimulation in Multiple Sclerosis patients with spasticity. The main questions it aims to answer are: - to evaluate the short-term impact of EXOPULSE Mollii suit on balance in adult MS patients suffering from spasticity. - to assess the effects of EXOPULSE Mollii suit on mobility, upper and lower limbs muscle tone, pain, fatigue and quality of life. Participants will participate in: - One baseline visit for inclusion during which the patient will undergo the first session (active or sham) along with evaluations (before and after the session) - One visit after two weeks during which the patient will undergo the second session (active or sham) along with evaluations (before and after the session) - One visit after two weeks of the second stimulation condition; the patients will undergo a third evaluation and receive the EXOPULSE Mollii Suit for the four-week open label phase and will use the suit at home for an active stimulation session every other day for four weeks. - One visit at the end of the open label phase to perform the fourth and last evaluation and return the EXOPULSE Mollii suit. Researchers will compare both Active and Sham groups to demonstrate the improvement of motor functions related symptoms in patients with MS and spasticity using Exopulse Mollii suit.
The study is a randomized crossover, sham-controlled, double-blind trial to demonstrate the improvement of motor functions and MS related symptoms following a single session of "active" versus "sham" EXOPULSE Mollii suit stimulation. in phase 1, the patient will receive two stimulations separated by a two-week washout period. The patients will be randomized to receive either active/sham or sham/active and both patients and investigators will be blinded to the order in which the stimulation will be given. A 2-week washout period should be enough to prevent a potential carry over effect. Two weeks after the end of phase 1, a second open label phase (phase 2) of this trial will be proposed to all patients where they will receive active stimulation every other day at home over four weeks (for a total of 14 sessions). This will help understand the long term effects of EXOPULSE Mollii suit stimulation on MS related symptoms. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Completed |
NCT03908580 -
MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity
|
Phase 4 | |
Not yet recruiting |
NCT04550793 -
Using Shear Wave Ultrasound Elastography for Follow up After Anti-spastic Intervention Among Stroke Patients
|
||
Recruiting |
NCT05432999 -
Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury
|
N/A | |
Completed |
NCT05687097 -
Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury
|
||
Active, not recruiting |
NCT05562453 -
Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain
|
N/A | |
Recruiting |
NCT06214975 -
EXOPULSE Mollii Suit, Motor Function & Stroke (EXOSTROKE 2)
|
N/A | |
Recruiting |
NCT05464160 -
Focal Muscular Vibration in Patients With Severe Acquired Brain Injury
|
N/A | |
Completed |
NCT04130295 -
Influence of Wearable Intensive Nerve Stimulation on Spasticity and Function in Persons With Spinal Cord Injury
|
N/A | |
Recruiting |
NCT06070233 -
Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy
|
N/A | |
Completed |
NCT03747900 -
Dry Needling and Botulinum Toxin in the Management of Poststroke Spasticity
|
N/A | |
Completed |
NCT03307135 -
Medical Spastic Patient Machine Interface MSPMI : Biomechanical and Electrophysiological Assessment of the Triceps Surae Spasticity
|
N/A | |
Recruiting |
NCT05070780 -
Neurophysiological Evaluation of Muscle Tone
|
||
Recruiting |
NCT04620707 -
RGS@Home: Personalized 24/7 Home Care Post-stroke
|
N/A | |
Recruiting |
NCT06109129 -
Investıgatıon Of The Effectıveness Of The Mollıı Suıt In Chıldren Wıth Ambulatory Cerebral Palsy
|
N/A | |
Enrolling by invitation |
NCT05598736 -
Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain
|
N/A | |
Completed |
NCT05103202 -
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
|
||
Active, not recruiting |
NCT05626790 -
Effects of PNF and Static Stretching on Architecture and Viscoelastic Properties of Hemiplegic Elbow
|
N/A | |
Recruiting |
NCT04904016 -
Pilot Investigation to Evaluate FlowOx2.0™ for Experimental Treatment of Spasticity
|
N/A | |
Withdrawn |
NCT05887479 -
The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity
|
Phase 4 |